Journal article · 2018 · Open access
Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication
Frontiers in Immunology, 9, 492 · Published 20 March 2018 · DOI 10.3389/fimmu.2018.00492
In brief
“Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication” is a 2018 journal article by Kumudhini Preethi Haran and 8 co-authors, published in Frontiers in Immunology. OpenAlex counts 77 citations as of 19 November 2026, which puts it in the top 3% of works published in 2018 by citations. It is open access under a CC BY licence: the full text is free to read at Frontiers in Immunology.
- Citations
- 77
- Most cited in
- 2022 (14)
- Field-weighted impact
- 4.43
- References
- 86
- Authors
- 9
Abstract
There is a need to develop improved methods to treat and potentially cure HIV infection. During chronic HIV infection, replication is concentrated within T follicular helper cells (Tfh) located within B cell follicles, where low levels of virus-specific CTL permit ongoing viral replication. We previously showed that elevated levels of SIV-specific CTL in B cell follicles are linked to both decreased levels of viral replication in follicles and decreased plasma viral loads. These findings provide the rationale to develop a strategy for targeting follicular viral-producing (Tfh) cells using anti-viral chimeric antigen receptor (CAR) T cells co-expressing the follicular homing chemokine receptor CXCR5. We hypothesize that anti-viral CAR/CXCR5 expressing T cells, when infused into an SIV-infected animal or an HIV-infected individual, will home to B cell follicles, suppress viral replication, and lead to long-term durable remission of SIV and HIV. To begin to test this hypothesis, we engineered gammaretroviral transduction vectors for co-expression of a bispecific anti-SIV CAR and rhesus macaque CXCR5. Viral suppression by CAR/CXCR5-transduced T cells was measured in vitro, and CXCR5-mediated migration was evaluated using both an in vitro trans-well migration assay, as well as a novel ex vivo tissue migration assay. The functionality of the CAR/CXCR5 T cells was demonstrated through their potent suppression of SIVmac239 and SIVE660 replication in in vitro and migration to the ligand CXCL13 in vitro, and concentration in B cell follicles in tissues ex vivo. These novel anti-viral immunotherapy products have the potential to provide long-term durable remission (functional cure) of HIV and SIV infections.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Haran, K. P., Hajduczki, A., Pampusch, M. S., Mwakalundwa, G., Vargas‐Inchaustegui, D. A., Rakasz, E. G., Connick, E., Berger, E. A., & Skinner, P. J. (2018). Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication. Frontiers in Immunology, 9, 492. https://doi.org/10.3389/fimmu.2018.00492
MLA 9
Haran, Kumudhini Preethi, et al. “Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication.” Frontiers in Immunology, vol. 9, 2018, p. 492. https://doi.org/10.3389/fimmu.2018.00492.
Chicago
Haran, Kumudhini Preethi, Agnes Hajduczki, Mary S. Pampusch, Gwantwa Mwakalundwa, Diego A. Vargas‐Inchaustegui, Eva G. Rakasz, Elizabeth Connick, Edward A. Berger, and Pamela J. Skinner. 2018. “Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication.” Frontiers in Immunology 9: 492. https://doi.org/10.3389/fimmu.2018.00492.
Harvard
Haran, K. P. et al. (2018) ‘Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication’, Frontiers in Immunology, 9, p. 492. doi:10.3389/fimmu.2018.00492.
IEEE
K. P. Haran et al., “Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication,” Frontiers in Immunology, vol. 9, p. 492, 2018, doi: 10.3389/fimmu.2018.00492.
BibTeX
@article{haran2018simian,
title = {{Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication}},
author = {Haran, Kumudhini Preethi and Hajduczki, Agnes and Pampusch, Mary S. and Mwakalundwa, Gwantwa and Vargas‐Inchaustegui, Diego A. and Rakasz, Eva G. and Connick, Elizabeth and Berger, Edward A. and Skinner, Pamela J.},
journal = {Frontiers in Immunology},
year = {2018},
volume = {9},
pages = {492},
doi = {10.3389/fimmu.2018.00492},
url = {https://doi.org/10.3389/fimmu.2018.00492}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2018 | 7 | |
| 2019 | 13 | |
| 2020 | 11 | |
| 2021 | 9 | |
| 2022 | 14 | |
| 2023 | 5 | |
| 2024 | 7 | |
| 2025 | 6 | |
| 2026 | 5 |
Its field-weighted citation impact is 4.43: it has been cited 4.43 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- simian immunodeficiency virus
- HIV cure
- chimeric antigen receptor T cells
- CXCR5
- B cell follicles
- T follicular helper cells
- viral replication inhibition
- CXCL13
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Haran, K. P., Hajduczki, A., Pampusch, M. S., Mwakalundwa, G., Vargas‐Inchaustegui, D. A., Rakasz, E. G., Connick, E., Berger, E. A., & Skinner, P. J. (2018). Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication. Frontiers in Immunology, 9, 492. https://doi.org/10.3389/fimmu.2018.00492
How many times has this paper been cited?
77 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Frontiers in Immunology: sign in and open the PDF from this page.
Who wrote this paper?
Kumudhini Preethi Haran, Agnes Hajduczki, Mary S. Pampusch, Gwantwa Mwakalundwa, Diego A. Vargas‐Inchaustegui, Eva G. Rakasz, Elizabeth Connick, Edward A. Berger, Pamela J. Skinner.
What is the DOI of this paper?
10.3389/fimmu.2018.00492, permanently at https://doi.org/10.3389/fimmu.2018.00492. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.